MYO1C
Unconventional myosin-Ic
Also known as: MYO1C_HUMAN, MyoIC, myr2, NMI
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00159
- Gene
- MYO1C
- Ensembl
- ENSG00000197879
- Chromosome
- 17
- Canonical length
- 1063 aa
- Protein class
- Predicted intracellular proteins, Transporters
- Subcellular location
- Nuclear bodies,Plasma membrane
OverviewNCBI Gene
This gene encodes a member of the unconventional myosin protein family, which are actin-based molecular motors. The protein is found in the cytoplasm, and one isoform with a unique N-terminus is also found in the nucleus. The nuclear isoform associates with RNA polymerase I and II and functions in transcription initiation. The mouse ortholog of this protein also functions in intracellular vesicle transport to the plasma membrane. Multiple transcript variants encoding different isoforms have been found for this gene. The related gene myosin IE has been referred to as myosin IC in the literature, but it is a distinct locus on chromosome 19. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1063 residues, UniProt reviewed canonical sequence.
>O00159|MYO1C
1 MALQVELVPT GEIIRVVHPH RPCKLALGSD GVRVTMESAL TARDRVGVQD FVLLENFTSE
61 AAFIENLRRR FRENLIYTYI GPVLVSVNPY RDLQIYSRQH MERYRGVSFY EVPPHLFAVA
121 DTVYRALRTE RRDQAVMISG ESGAGKTEAT KRLLQFYAET CPAPERGGAV RDRLLQSNPV
181 LEAFGNAKTL RNDNSSRFGK YMDVQFDFKG APVGGHILSY LLEKSRVVHQ NHGERNFHIF
241 YQLLEGGEEE TLRRLGLERN PQSYLYLVKG QCAKVSSIND KSDWKVVRKA LTVIDFTEDE
301 VEDLLSIVAS VLHLGNIHFA ANEESNAQVT TENQLKYLTR LLSVEGSTLR EALTHRKIIA
361 KGEELLSPLN LEQAAYARDA LAKAVYSRTF TWLVGKINRS LASKDVESPS WRSTTVLGLL
421 DIYGFEVFQH NSFEQFCINY CNEKLQQLFI ELTLKSEQEE YEAEGIAWEP VQYFNNKIIC
481 DLVEEKFKGI ISILDEECLR PGEATDLTFL EKLEDTVKHH PHFLTHKLAD QRTRKSLGRG
541 EFRLLHYAGE VTYSVTGFLD KNNDLLFRNL KETMCSSKNP IMSQCFDRSE LSDKKRPETV
601 ATQFKMSLLQ LVEILQSKEP AYVRCIKPND AKQPGRFDEV LIRHQVKYLG LLENLRVRRA
661 GFAYRRKYEA FLQRYKSLCP ETWPTWAGRP QDGVAVLVRH LGYKPEEYKM GRTKIFIRFP
721 KTLFATEDAL EVRRQSLATK IQAAWRGFHW RQKFLRVKRS AICIQSWWRG TLGRRKAAKR
781 KWAAQTIRRL IRGFVLRHAP RCPENAFFLD HVRTSFLLNL RRQLPQNVLD TSWPTPPPAL
841 REASELLREL CIKNMVWKYC RSISPEWKQQ LQQKAVASEI FKGKKDNYPQ SVPRLFISTR
901 LGTDEISPRV LQALGSEPIQ YAVPVVKYDR KGYKPRSRQL LLTPNAVVIV EDAKVKQRID
961 YANLTGISVS SLSDSLFVLH VQRADNKQKG DVVLQSDHVI ETLTKTALSA NRVNSININQ
1021 GSITFAGGPG RDGTIDFTPG SELLITKAKN GHLAVVAPRL NSRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYO1C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 159 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 159 nTPM
- blood vessel: 144 nTPM
- breast: 115 nTPM
- colon: 101 nTPM
- heart muscle: 94 nTPM
- endometrium: 93 nTPM
Single-cell type
- alveolar cells type 1: 295 nCPM
- adipocytes: 194 nCPM
- colonocytes: 146 nCPM
- goblet cells: 139 nCPM
- vascular smooth muscle cells: 138 nCPM
- retinal pigment epithelial cells: 115 nCPM
Immune cell
- memory B-cell: 4.8 nTPM
- naive B-cell: 3.8 nTPM
- memory CD4 T-cell: 2.1 nTPM
- intermediate monocyte: 2 nTPM
- T-reg: 1.9 nTPM
- non-classical monocyte: 1.7 nTPM
Brain region
- choroid plexus: 31 nTPM
- hypothalamus: 26 nTPM
- pons: 26 nTPM
- thalamus: 24 nTPM
- medulla oblongata: 23 nTPM
- cerebellum: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.64
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- actin filament-based movement
- cellular response to type II interferon
- chromatin remodeling
- endocytosis
- positive regulation of cell migration
- positive regulation of cellular response to insulin stimulus
- positive regulation of protein targeting to membrane
- positive regulation of transcription by RNA polymerase I
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription by RNA polymerase III
- protein targeting to membrane
- regulation of bicellular tight junction assembly
- vascular endothelial growth factor signaling pathway
- vesicle transport along actin filament
Molecular functions
- actin filament binding
- ATP binding
- calmodulin binding
- microfilament motor activity
- signaling receptor binding
- small GTPase binding
Cellular components
- actin cytoskeleton
- B-WICH complex
- basal plasma membrane
- brush border
- cell cortex
- cytoplasm
- cytoplasmic vesicle membrane
- cytosol
- extracellular exosome
- filamentous actin
- lateral plasma membrane
- membrane
- membrane raft
- microvillus
- nuclear body
- nucleolus
- nucleoplasm
- phagocytic vesicle
- plasma membrane
- ruffle membrane
- stereocilium membrane
- unconventional myosin complex
Protein domainsUniProt · Pfam · InterPro
- IQ motif, EF-hand binding site
- Myosin head, motor domain-like
- Class I myosin tail homology domain
- P-loop containing nucleoside triphosphate hydrolase
- Class I myosin, motor domain
- Kinesin motor domain superfamily
- Myosin head (motor domain)
- IQ calmodulin-binding motif
- Unconventional myosin tail, actin- and lipid-binding
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MYO1C in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYO1C as an antibody target. Whether an autoantibody or antibody against MYO1C could matter depends on whether native MYO1C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYO1C is annotated at the cell surface, where native MYO1C is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MYO1C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...